Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types - Archive ouverte HAL Access content directly
Journal Articles (Review Article) Cancers Year : 2022

Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types

(1) , (1) , (1) , (1) , (1) , (1)
1

Abstract

The first cause of death in cancer patients, after tumoral progression itself, is thrombo-embolic disease. This cancer-associated hypercoagulability state is known as Trousseau’s syndrome, and the risk for developing thrombotic events differs according to cancer type and stage, as well as within patients. Massive platelet activation by tumor cells is the key mediator of thrombus formation in Trousseau’s syndrome. In this literature review, we aimed to compare the interactions between cancer cells and platelets in three different cancer types, with low, medium and high thrombotic risk. We chose oral squamous cell carcinoma for the low-thrombotic-risk, colorectal adenocarcinoma for the medium-thrombotic-risk, and pancreatic carcinoma for the high-thrombotic-risk cancer type. We showcase that understanding these interactions is of the highest importance to find new biomarkers and therapeutic targets for cancer-associated thrombosis.
Fichier principal
Vignette du fichier
palacios-acedo_cancers-2022.pdf (1.41 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03777352 , version 1 (14-09-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Ana-Luisa Palacios-Acedo, Mélanie Langiu, Lydie Crescence, Diane Mège, Christophe Dubois, et al.. Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types. Cancers, 2022, 14 (3), pp.730. ⟨10.3390/cancers14030730⟩. ⟨hal-03777352⟩
19 View
4 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More